Seeman (2006) — Bone quality--the material and structural basis of bone strength and fragility.

Bone Quality--The Material and Structural Basis of Bone Strength and Fragility.

Seeman, Delmas·N Engl J Med·2006·2,052 citations·Basic Science

This 2006 NEJM review by Seeman and Delmas examines what determines bone strength beyond density. It defines how material composition (mineral content, collagen cross-linking) and structural design (cortical geometry, trabecular architecture) interact to resist fracture. It then explains how age-related failure of bone modeling and remodeling leads to fragility — and why this matters for how we use antiresorptive and anabolic drugs.

Key Findings

Human bone is ~60% mineralized — a deliberate compromise between stiffness and flexibility.
–Too stiff (like auditory ossicles at 90%) → brittle.
–Too flexible (like antlers at 40%) → deforms and cracks.
–This balance is why deviations from normal mineralization in either direction increase fracture risk.
Loss of trabecular connectivity causes greater structural weakness than thinning alone.
–Deep resorption cavities perforate and disconnect trabecular plates entirely.
–A disconnected plate contributes zero load-bearing capacity. A thinned plate still contributes.
Men and women lose bone by different mechanisms. This is why fracture patterns differ by sex:
–Men: trabecular thinning (reduced BMU formation)
–Women: trabecular perforation (increased BMU resorption)
–This explains why women lose vertebral strength faster despite similar volumetric density early in life.
Women with fragility fractures show heterogeneous BMU pathology. Remodeling rates can be high, normal, or low.
–Identical DXA scores can reflect fundamentally different disease mechanisms.
–The authors argue this means not all fragility fracture patients should be treated identically.
Antiresorptive agents reduce early fracture risk by completing pre-existing remodeling cycles. Not just by raising BMD.
–Prolonged suppression risks microdamage accumulation and increased brittleness, especially in patients with low baseline remodeling rates and normal tissue mineral density.

Board PearlTrabecular perforation causes greater weakness than thinning alone — this is why estrogen deficiency fractures differently than aging in men.

Clinical Relevance

DXA measures a shadow of bone mass, not bone quality. Two patients with identical T-scores can have completely different fracture risk based on trabecular architecture, tissue mineral density, and remodeling rate — none of which appear on the scan.

When a patient sustains a fragility fracture with a "borderline" DXA, do not dismiss the fracture as incidental. This paper explains why: perforation of trabecular connectivity. Not thinning. Is often the structural event that tips bone into failure, and it happens before DXA detects significant density loss.

For bisphosphonate prescribing: early fracture risk reduction comes from completing pre-existing remodeling cycles, so patients benefit quickly. But in patients with already low remodeling rates and normal tissue mineral density, further suppression may accumulate microdamage rather than prevent it. The mechanism behind atypical femur fractures.

Teriparatide's fracture prevention efficacy is similar regardless of baseline remodeling rate, making it a rational choice when the remodeling machinery itself is depleted rather than merely overactive.

Bone Quality--The Material and Structural Basis of Bone Strength and Fragility.

Key Findings

Clinical Relevance

Related Articles

Bone Quality--The Material and Structural Basis of Bone Strength and Fragility.

Key Findings

Clinical Relevance

Related Articles

Bone Quality--The Material and Structural Basis of Bone Strength and Fragility.

Key Findings

Clinical Relevance

Related Articles

Bone Quality--The Material and Structural Basis of Bone Strength and Fragility.

Key Findings

Clinical Relevance

Related Articles